Latest Articles
Cost-Effectiveness Of Durvalumab For Endometrial Cancer Uncovered - Evrim Ağacı
Cost-Effectiveness Of Durvalumab For Endometrial Cancer Uncovered Evrim Ağacı
Published: Jan. 21, 2025, 9:50 p.m.
Reduced cost-effectiveness reported from HPV vaccination in mid-adults - Contemporary Obgyn
Reduced cost-effectiveness reported from HPV vaccination in mid-adults Contemporary Obgyn
Published: Nov. 27, 2024, 2:56 p.m.
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer - Frontiers
Cost-effectiveness of dostarlimab plus chemotherapy for primary advanced or recurrent endometrial cancer Frontiers
Published: June 20, 2024, 7 a.m.
Link copied to clipboard!